POZ - Latino Hub : Treatment News : Many Prisoners Revert to Intermittent Treatment After Incarceration

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007


emailrssprint

October 1, 2009

Many Prisoners Revert to Intermittent Treatment After Incarceration

Less than 17 percent of HIV-positive inmates on antiretroviral (ARV) therapy continue taking their treatment consistently once they are released from prison, according to a study published September 22 in the online journal PLoS One.

Though there are often still many barriers to effective HIV therapy in prison, researchers have known that some incarcerated people are better able to access and adhere to ARV treatment while in prison than after they are released. Potential reasons for this include lack of housing, employment, access to care and social support.

To determine the rate of continuous HIV treatment after release from prison, Nitika Pant Pai, MD, from the McGill University Health Center in Montreal, and her colleagues studied 512 HIV-positive individuals doing repeated stints in the San Francisco County jail system. The study was conducted during a nine-year period.

Seventy-six percent of the study participants reported taking their HIV medications only intermittently between sentences or after leaving prison. Fifteen percent reported using their ARVs continuously, and 9 percent were never on therapy at all. Of the 497 who were on treatment for at least some period during the study, 16.9 percent remained on treatment continuously.

“The optimal solution for treating patients and controlling the HIV epidemic in the USA is to ensure continuous therapy,” claimed Milton Estes, MD, medical director of Forensic AIDS Project, San Francisco, in a press release from McGill University. “To achieve this we must work on various aspects of the prisoners’ lives, such as marginalization, psychiatric problems and drug use, both before and after their departure from prison.”

Jacqueline Tulsky, MD, from the University of California at San Francisco and a coauthor of the study, concludes, “This research highlights the need to examine ARV policies inside and outside correctional settings with a view to establishing effective lifelong management of HIV in prisoners.”

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]

Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.